Seattle Genetics, Inc. and Takeda Pharmaceutical Co. Ltd. Leads Roche in Race to Develop Combo Cancer Therapy
Bloomberg -- Seattle Genetics Inc. and Takeda Pharmaceutical Co. may beat Roche Holding AG in developing a new type of combination cancer therapy that’s less toxic than standard treatments.